menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

12 0
04.02.2025
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

© Fortune